Clinical trial
Serial PSMA PET Imaging in the Assessment of Treatment Response in Patients With Progressive Prostate Cancer
NCT04030338 is registered in ClinicalTrials.gov with Memorial Sloan Kettering Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Serial PSMA PET Imaging in the Assessment of Treatment Response in Patients With Progressive Prostate Cancer
- Lead sponsor
- Memorial Sloan Kettering Cancer Center
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- July 19, 2019
- Completion date
- July 31, 2027
- Enrollment
- 58 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
metastatic prostate cancer, prostate adenocarcinoma, prostate cancer, prostate cancer metastatic, prostate neoplasm